# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-010136
Filing Date
2025-03-13
Accepted
2025-03-13 07:30:40
Documents
76
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 1779208
2 |  | ex19-1.htm | EX-19.1 | 99200
3 |  | ex23-1.htm | EX-23.1 | 7268
4 |  | ex31-1.htm | EX-31.1 | 17411
5 |  | ex31-2.htm | EX-31.2 | 17393
6 |  | ex32-1.htm | EX-32.1 | 7417
7 |  | ex32-2.htm | EX-32.2 | 7259
8 |  | form10-k_0001.jpg | GRAPHIC | 29307
9 |  | form10-k_0002.jpg | GRAPHIC | 25784
10 |  | form10-k_0003.jpg | GRAPHIC | 47514
11 |  | form10-k_0004.jpg | GRAPHIC | 21559
12 |  | form10-k_0005.jpg | GRAPHIC | 25102
13 |  | fin_001.jpg | GRAPHIC | 25771
14 |  | form10-k_007.jpg | GRAPHIC | 164995
15 |  | form10-k_006.jpg | GRAPHIC | 104913
16 |  | ex23-1_001.jpg | GRAPHIC | 5212
17 |  | ex23-1_002.jpg | GRAPHIC | 6512
| Complete submission text file | 0001493152-25-010136.txt |  | 6667812

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
18 | XBRL SCHEMA FILE | indp-20241231.xsd | EX-101.SCH | 32350
19 | XBRL CALCULATION FILE | indp-20241231_cal.xml | EX-101.CAL | 49685
20 | XBRL DEFINITION FILE | indp-20241231_def.xml | EX-101.DEF | 107463
21 | XBRL LABEL FILE | indp-20241231_lab.xml | EX-101.LAB | 350841
22 | XBRL PRESENTATION FILE | indp-20241231_pre.xml | EX-101.PRE | 268709
79 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 489438

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40652 | Film No.: 25733840
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)